FDA Expands Cooperative Research And Development Study (CRADA) With Conformia
Jul 4th 2008Drug InformationPharma Industry
Conformia, the market leader of product and process lifecycle management (PPLM) solutions for life sciences, announced the U.S. Food and Drug Administration’s (FDA) Office of Pharmaceutical Sciences (OPS) has asked the Company to expand its Cooperative Research and Development Study (CRADA) focusing on process and product development to 25 companies.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.